{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:07:16Z","timestamp":1780499236574,"version":"3.54.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Geriatric Nursing"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.gerinurse.2016.06.012","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T11:49:03Z","timestamp":1468928943000},"page":"434-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Infusion treatments and deep brain stimulation in Parkinson's Disease: The role of nursing"],"prefix":"10.1016","volume":"37","author":[{"given":"Anna","family":"De Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tessitore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonilda","family":"Bilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"De Michele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gerinurse.2016.06.012_bib1","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"13","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/mds.26125","article-title":"Clinical spectrum of levodopa-induced complications","volume":"30","author":"Aquino","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib5","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/mds.20458","article-title":"Motor fluctuations and dyskinesias in Parkinson's disease: clinical manifestations","volume":"20","author":"Jankovic","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib6","first-page":"191","article-title":"Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study","volume":"16","author":"Valldeoriola","year":"2013","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib7","first-page":"344","article-title":"Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease","volume":"50","author":"Benabid","year":"1987","journal-title":"Appl Neurophysiol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/brain\/121.3.451","article-title":"Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson\u2019s disease","volume":"121","author":"Krack","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000353121","article-title":"Deep brain stimulation","volume":"1","author":"Chen","year":"2012","journal-title":"Interv Neurol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib10","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1056\/NEJMoa0907083","article-title":"Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease","volume":"362","author":"Follett","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib11","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMct1208070","article-title":"Deep-brain stimulation for Parkinson's disease","volume":"367","author":"Okun","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib12","first-page":"2701","article-title":"Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based review","volume":"260","author":"Volkmann","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.parkreldis.2014.01.012","article-title":"Long-term outcome of subthalamic nucleus DBS in Parkinson\u2019s disease: from the advanced phase towards the late stage of the disease?","volume":"20","author":"Rizzone","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(08)70291-6","article-title":"Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson\u2019s disease","volume":"8","author":"Benabid","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.brs.2016.02.004","article-title":"Programming deep brain stimulation for Parkinson's disease: the Toronto Western hospital algorithms","volume":"9","author":"Picillo","year":"2016","journal-title":"Brain Stimul"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib16","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C","article-title":"Core assessment program for surgical interventional therapies in Parkinson\u2019s disease (CAPSIT-PD)","volume":"14","author":"Defer","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/mds.20955","article-title":"Deep brain stimulation: preoperative issues","volume":"21","author":"Lang","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.parkreldis.2012.07.004","article-title":"Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study","volume":"19","author":"Deuschl","year":"2013","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib19","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archneur.58.8.1223","article-title":"Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease","volume":"58","author":"Alegret","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib20","first-page":"603","article-title":"Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson\u2019s disease","volume":"248","author":"Dujardin","year":"2001","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib21","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1212\/01.WNL.0000032756.14298.18","article-title":"Effect on mood of subthalamic DBS for Parkinson\u2019s disease: a consecutive series of 24 patients","volume":"59","author":"Berney","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2176\/nmc.ra.2014-0446","article-title":"Deep brain stimulation for Parkinson's disease: recent trends and future direction","volume":"55","author":"Fukaya","year":"2015","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1015-9584(09)60404-8","article-title":"Complications of deep brain stimulation: a collective review","volume":"32","author":"Chan","year":"2009","journal-title":"Asian J Surg"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib24","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1212\/01.wnl.0000234881.77830.66","article-title":"Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study","volume":"66","author":"Smeding","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib25","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1212\/01.WNL.0000144198.26309.D8","article-title":"Subthalamic nucleus deep brain stimulation in Parkinson disease patients over 70 year","volume":"63","author":"Russmann","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01376517-200412000-00003","article-title":"High-frequency stimulation of the subthalamic nucleus for the treatment of Parkinson's disease\u2013a team perspective","volume":"36","author":"Sanghera","year":"2004","journal-title":"J\u00a0Neurosci Nurs"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0001-2092(06)61274-X","article-title":"Deep brain stimulation for advanced Parkinson's disease","volume":"72","author":"Byrd","year":"2000","journal-title":"AORN J"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/01376517-200508000-00006","article-title":"Nursing time to program and assess deep brain stimulators in movement disorder patients","volume":"37","author":"Hunka","year":"2005","journal-title":"J\u00a0Neurosci Nurs"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib29","first-page":"251","article-title":"Apomorphine in Parkinson\u2019s disease","volume":"56","author":"Schwab","year":"1951","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0753-3322(96)82620-5","article-title":"Apomorphine in patients with Parkinson\u2019s disease","volume":"49","author":"Muguet","year":"1995","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40263-014-0221-z","article-title":"Role of apomorphine in the treatment of Parkinson's disease","volume":"29","author":"Boyle","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib32","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1212\/WNL.62.6_suppl_4.S22","article-title":"Other formulations and future considerations for apomorphine for subcutaneous injection therapy","volume":"62","author":"Koller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib33","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jnnp.2005.078659","article-title":"Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson\u2019s disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus","volume":"77","author":"De Gaspari","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib34","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/mds.20237","article-title":"Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease","volume":"19","author":"Alegret","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2011.08.010","article-title":"Apomorphine infusion in advanced Parkinson\u2019s patients with subthalamic stimulation contraindications","volume":"18","author":"Drapier","year":"2012","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib36","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.parkreldis.2015.06.012","article-title":"Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease\u2013clinical practice recommendations","volume":"21","author":"Trenkwalder","year":"2015","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1586\/ern.09.48","article-title":"Apomorphine and levodopa infusion therapies for advanced Parkinson\u2019s disease: selection criteria and patient management","volume":"9","author":"Antonini","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib38","first-page":"4","article-title":"Apomorphine and levodopa infusion therapies for advanced Parkinson's disease","volume":"2","author":"Antonini","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib39","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nrl.2013.05.002","article-title":"Advanced Parkinson's disease: clinical characteristics and treatment. Part II","volume":"28","author":"Kulisevsky","year":"2013","journal-title":"Neurologia"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib40","first-page":"23","article-title":"Apomorphine treatment: a nurse\u2019s perspective","volume":"2","author":"McGee","year":"2002","journal-title":"Adv Clin Neurosci Rehabil"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mds.26078","article-title":"Novel formulations and modes of delivery of levodopa","volume":"30","author":"Poewe","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1212\/01.WNL.0000149637.70961.4C","article-title":"Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease","volume":"64","author":"Nyholm","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib43","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1586\/14737175.6.10.1403","article-title":"Enteral levodopa\/carbidopa gel infusion for the treatment of motor fluctuations and dyskinesias in advanced Parkinson\u2019s disease","volume":"6","author":"Nyholm","year":"2006","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib44","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/mds.21500","article-title":"Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome","volume":"22","author":"Antonini","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000113714","article-title":"Duodenal levodopa infusion improves quality of life in advanced Parkinson\u2019s disease","volume":"5","author":"Antonini","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib46","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/mds.23524","article-title":"Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson\u2019s disease","volume":"26","author":"Merola","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib47","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/ene.12309","article-title":"Levodopa\/carbidopa intestinal gel infusion in advanced Parkinson's disease: a 7-year experience","volume":"21","author":"Zibetti","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1874205X01206010037","article-title":"Practical guidance on how to handle levodopa\/carbidopa intestinal gel therapy of advanced PD in a movement disorder clinic","volume":"6","author":"Pedersen","year":"2012","journal-title":"Open Neurol J"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib49","first-page":"147","article-title":"Continuous intestinal infusion of levodopa\/carbidopa in advanced Parkinson's disease: ef\ufb01cacy, safety and patient selection","volume":"27","author":"Abbruzzese","year":"2012","journal-title":"Funct Neurol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib50","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/mds.22450","article-title":"Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson\u2019s disease","volume":"24","author":"Devos","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.22021","article-title":"Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease","volume":"68","author":"Toth","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.gerinurse.2016.06.012_bib52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00702-011-0689-3","article-title":"Malnutritional neuropathy under intestinal levodopa infusion","volume":"119","author":"Klostermann","year":"2012","journal-title":"J\u00a0Neural Transm"}],"container-title":["Geriatric Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197457216300908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197457216300908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:58:37Z","timestamp":1759316317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197457216300908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0197457216300908"],"URL":"https:\/\/doi.org\/10.1016\/j.gerinurse.2016.06.012","relation":{},"ISSN":["0197-4572"],"issn-type":[{"value":"0197-4572","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infusion treatments and deep brain stimulation in Parkinson's Disease: The role of nursing","name":"articletitle","label":"Article Title"},{"value":"Geriatric Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gerinurse.2016.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}